U.S. Cannabis testing market is estimated to record a significant growth rate of 9.6% through 2027 owing to the presence of large number of manufacturers and cultivators of cannabis and its products in the zone. In addition, growing legalization of medical and adult-use of cannabis coupled with increasing support from various government bodies is likely to support the business growth further. Citing an instance, ANSI National Accreditation Board (ANAB) gives accreditation to several independent and third-party laboratories which provide cannabis testing services.

Get sample copy of this research report @ https://www.decresearch.com/request-sample/detail/4481

Based on technology bifurcation, Liquid chromatography (LC) is expected to register commendable growth over the forthcoming years as majority of cannabis testing procedures are carried out using LC. It is a valuable alternative method for gas chromatography for analyzing the cannabinoids, pesticides and THC. Further, in the case of LC, the purification standards are highly controlled which provides accurate results, which complements the growth of liquid chromatography segment. For the records, in 2020, the segment had accounted for a substantial valuation of USD 662.4 million.

Based on the test type, heavy metal testing segment recorded a significant valuation of USD 352.5 million in 2020 and is expected to grow over upcoming years. This can be credited to the increasing demand for this testing type as heavy metals are one of the major contaminants in cannabis and its products among other contaminants such as pesticides, residual solvents and microbial organisms. Moreover, compulsion regarding heavy metal testing of heavy metals by several government organizations and increasing legalization of cannabis for medicinal and recreational use will positively influence the segment growth.

Prominent players operating in the U.S. cannabis testing market such as CannaSafe, Anresco, Collective Wellness of California, EVIO, Inc., Digipath, Inc, PSI Labs, SC Labs, Inc., Steep Hill, Inc. etc. are focusing on developing enhanced cannabis testing solutions and accreditation for gaining strong market presence worldwide. For instance, in 2018, CannaSafe announced that it received accreditation for laboratory analysis of medical cannabis products as a part of the Americans for Safe Access Patient Focused Certification program. This is a third-party certification program designed specifically for medical cannabis industry.

As majority of cannabis testing procedures are carried out using liquid chromatography, it is estimated to witness higher preference over the coming years. In 2020, liquid chromatography segment recorded a valuation of USD 662.4 million. Further, liquid chromatography is a valuable alternative to gas chromatography when it comes to analysis of cannabinoids, pesticides and THC which is why this technology is often preferred for potency testing as it offers more precise analysis. Moreover, purification standards are highly controlled in liquid chromatography which helps in obtaining accurate results, which is complementing the segment growth.

Request for a Customization of this research report @ https://www.decresearch.com/roc/4481

Partial Chapter of the Table of Content

Chapter 4   U.S. Cannabis Testing Market, By Technology

4.1    Key segment trends

4.2    Chromatography

4.2.1    Market size, by zone, 2016 - 2027 (USD Million)

4.2.2    Liquid chromatography

4.2.2.1    Market size, by zone, 2016 - 2027 (USD Million)

4.2.3    Gas chromatography

4.2.3.1    U.S. Cannabis Testing Market size, by zone, 2016 - 2027 (USD Million)

4.2.4    Others

4.2.4.1    Market size, by zone, 2016 - 2027 (USD Million)

4.3    Spectroscopy

4.3.1    Market size, by zone, 2016 - 2027 (USD Million)

4.3.2    Mass spectroscopy

4.3.2.1    Market size, by zone, 2016 - 2027 (USD Million)

4.3.3    Atomic spectroscopy

4.3.3.1    Market size, by zone, 2016 - 2027 (USD Million)

Chapter 5   U.S. Cannabis Testing Market, By Test Type

5.1    Key segment trends

5.2    Potency testing

5.2.1    U.S. Cannabis Testing Market size, by zone, 2016 - 2027 (USD Million)

5.3    Pesticide screening

5.3.1    Market size, by zone, 2016 - 2027 (USD Million)

5.4    Residual solvent screening

5.4.1    Market size, by zone, 2016 - 2027 (USD Million)

5.5    Heavy metal testing

5.5.1    Market size, by zone, 2016 - 2027 (USD Million)

5.6    Terpene testing

5.6.1    U.S. Cannabis Testing Market size, by zone, 2016 - 2027 (USD Million)

5.7    Mycotoxin testing

Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/us-cannabis-testing-market